[go: up one dir, main page]

ZA200804815B - Matrix-controlled transdermal system comprising salts of ACE inhibitor dicarboxylic acids - Google Patents

Matrix-controlled transdermal system comprising salts of ACE inhibitor dicarboxylic acids

Info

Publication number
ZA200804815B
ZA200804815B ZA200804815A ZA200804815A ZA200804815B ZA 200804815 B ZA200804815 B ZA 200804815B ZA 200804815 A ZA200804815 A ZA 200804815A ZA 200804815 A ZA200804815 A ZA 200804815A ZA 200804815 B ZA200804815 B ZA 200804815B
Authority
ZA
South Africa
Prior art keywords
salts
matrix
ace inhibitor
dicarboxylic acids
transdermal system
Prior art date
Application number
ZA200804815A
Other languages
English (en)
Inventor
Klokkers Karin
Helfrich Michael
Nink Joerg
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of ZA200804815B publication Critical patent/ZA200804815B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200804815A 2005-12-05 2006-12-05 Matrix-controlled transdermal system comprising salts of ACE inhibitor dicarboxylic acids ZA200804815B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005058166A DE102005058166A1 (de) 2005-12-05 2005-12-05 Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren

Publications (1)

Publication Number Publication Date
ZA200804815B true ZA200804815B (en) 2009-10-28

Family

ID=38047709

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200804815A ZA200804815B (en) 2005-12-05 2006-12-05 Matrix-controlled transdermal system comprising salts of ACE inhibitor dicarboxylic acids

Country Status (12)

Country Link
US (1) US20090162420A1 (ru)
EP (1) EP1959938B1 (ru)
JP (1) JP2009518336A (ru)
CN (1) CN101321521A (ru)
AT (1) ATE506943T1 (ru)
AU (1) AU2006322301A1 (ru)
BR (1) BRPI0619419A2 (ru)
CA (1) CA2630500A1 (ru)
DE (2) DE102005058166A1 (ru)
RU (1) RU2008127169A (ru)
WO (1) WO2007065638A2 (ru)
ZA (1) ZA200804815B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007112294A1 (en) 2006-03-24 2007-10-04 Henkel Corporation Sprayable water-based adhesive
US7943655B2 (en) * 2006-04-05 2011-05-17 Universitat Zurich Polymorphic and pseudopolymorphic forms of trandolaprilat, pharmaceutical compositions and methods for production and use
EP2537534B1 (en) 2011-06-22 2014-12-17 Hexal AG Esters of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their therapeutic use.
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
CN105213355A (zh) * 2015-11-09 2016-01-06 徐静 一种含有雷米普利的外用缓释透皮贴剂及其应用
JP2022183114A (ja) * 2021-05-28 2022-12-08 アピ株式会社 ゼラチンカプセル崩壊遅延低減剤、ゼラチンカプセル、及びゼラチンカプセル用皮膜

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073539A (en) 1990-01-22 1991-12-17 Ciba-Geigy Corporation Transdermal administration of zwitterionic drugs
JP2849937B2 (ja) 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
DE19512181C2 (de) 1995-03-31 2003-11-06 Hexal Pharma Gmbh Transdermales System mit Ramipril und/oder Trandolapril als ACE-Hemmer
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
DE19913528A1 (de) * 1998-12-21 2000-06-29 Sanol Arznei Schwarz Gmbh Neue Verwendung von Moexipril
FR2807431B1 (fr) * 2000-04-06 2002-07-19 Adir Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
DE10033855A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Matrixkontrolliertes transdermales System mit Sulfonsäuresalz eines ACE-Hemmers
GB2395195A (en) * 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors

Also Published As

Publication number Publication date
US20090162420A1 (en) 2009-06-25
EP1959938B1 (de) 2011-04-27
AU2006322301A1 (en) 2007-06-14
WO2007065638A3 (de) 2007-09-07
CA2630500A1 (en) 2007-06-14
EP1959938A2 (de) 2008-08-27
WO2007065638A2 (de) 2007-06-14
CN101321521A (zh) 2008-12-10
DE102005058166A1 (de) 2007-06-06
DE502006009412D1 (de) 2011-06-09
ATE506943T1 (de) 2011-05-15
RU2008127169A (ru) 2010-03-27
BRPI0619419A2 (pt) 2011-10-04
JP2009518336A (ja) 2009-05-07

Similar Documents

Publication Publication Date Title
EP2915814A3 (en) Crystalline salts of sitagliptin
MY174776A (en) Polymorphic and pseudopolymorphic forms of a pharmaceutical compound
TNSN07452A1 (en) Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
ATE433988T1 (de) Phosphoramidatderivate
MY148258A (en) Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
UA105229C2 (ru) Фармацевтический состав
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
MX2013005533A (es) Derivados de acido amino-bisfenil-pentanoico sustituidos como inhibidores de nep.
EA201200763A1 (ru) Замещенные производные карбамоилметиламиноуксусной кислоты в качестве новых ингибиторов nep
MX2008010884A (es) Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1.
NZ593524A (en) A nonapeptide with anti-tumour activity
MY148953A (en) Substituted biphenyl carboxylic acids and derivatives thereof
PL2354235T3 (pl) Sposób fermentacyjnego wytwarzania L-aminokwasów z zastosowaniem bakterii maczugowatych
ZA200804815B (en) Matrix-controlled transdermal system comprising salts of ACE inhibitor dicarboxylic acids
ZA200800091B (en) Method for producing salts of hydrocyanic acid
IL183104A0 (en) Method for production of candesartan
CY1109762T1 (el) Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος
UA94042C2 (ru) Применение агомелатина в получении лекарственных средств, предназначенных для лечения синдрома смита-магениса
TW200621785A (en) Analgesic
CY1112979T1 (el) Διαδικασια για την παρασκευη της ενωσης (s)-1-αλκυλ-2',6'-πιπεκολοξυλιδιδιου
EA200900836A1 (ru) Способ получения высокочистой внутренней соли 3-карбокси-n,n,n-триметил-1-пропанаминий гидроксида
MX2010004261A (es) Acidos carboxilicos bifenil y derivados de los mismos.
TN2009000345A1 (en) Aryl carboxylic acid cyclohexyl amide derivatives
ATE423775T1 (de) Verfahren zur herstellung von lactonen
ATE517890T1 (de) Verfahren zur herstellung von reinem irbesartan